Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

NIRMATRELVIR AND RI

Active
SPE2DP-26-T-3985Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the procurement of Nirmatrelvir and Ritonavir tablets, marketed as Paxlovid, supplied by Pfizer Inc under part number NDC00069-5321-30, with a national stock number of 6505017227590. Each unit consists of a box containing ten blister cards, with each blister card providing one full daily dose comprising two 150 mg Nirmatrelvir tablets and one 100 mg Ritonavir tablet, sufficient for a five-day treatment course at two doses per day. The item is classified as a Type I (Code Q) pharmaceutical with a non-extendable shelf life of 36 months and is regulated by the FDA. The unit of issue is a box of ten, and delivery must be completed within 20 days of award to the designated destination: N23197 USNS CARL BRASHEAR T-AKE 7, UNIT 100204 BOX 1, FPO AP 96661. The contract specifies FOB destination terms, with zero tolerance for quantity variance, and requires inspection and acceptance at the delivery point. All packaging and marking must conform to commercial standards and comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, with palletization aligned with DLA Packaging Requirements for Procurement (RP001). Packaging must ensure the product is sealed in unit containers that safeguard against damage during transit and packed in suitable commercial shipping containers appropriate for safe and economical delivery by common carriers. The solicitation incorporates specific technical and quality requirements listed in the DLA Master List of Technical and Quality Requirements and mandates compliance with the Buy American Act, the Berry Amendment, and DFARS 252.225-7001. The contract includes critical cybersecurity and compliance clauses such as Safeguarding Covered Defense Information, Cyber Incident Reporting, Prohibition on Covered Telecommunications Equipment, and requirements for combating trafficking in persons, employment eligibility verification, and sustainable products, all under deviation 2026-00038. Offerors must be registered in SAM, represent their small business status accurately, and comply with all applicable FAR and DFARS clauses. The solicitation is a small business set-aside under NAICS code 325411, with quotes submitted exclusively via the DLA Internet Bid Board System by

General Info

Defense Logistics Agency seeks one unit of NIRMATRELVIR AND RI by July 13, 2026, via solicitation SPE2DP-26-T-3985.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

UNIT 100204 BOX 1, FPO, AP, 96661, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3985 Medical Supply Chain

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseSolicitation
Posted

Solicitation

Amendment 1

Contract was updated

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS

Full Description

Show more
NIRMATRELVIR AND RI
NIRMATRELVIR AND RITONAVIR TABLETS
PAXLOVIDNIRMATRELVIR 300 GM RITONAVIR
100 MG. 10 BLISTER CARDS. EACH BLISTER
CARD CONTAINS 3 TABLETS: 2 NIRMATRELVIR
TABLETS (150 MG EACH) 1 RITONAVIR TABLET
(100 MG EACH). EACH BLISTER CARD CONTAINS
ONE DOSE (MUST TAKE ALL THREE TABLETS).
BOX CONTAINS 5 DAY SUPPLY OF TWO DAILY DOSES.
.
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
. UNIT OF ISSUE BOX OF 10 EA . RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
BIDDER SHALL SPECIFY SOURCE AND
PART NUMBER BEING SUPPLIED.
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. .
PFIZER INC 86491 P/N NDC00069-5321-30
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7015405663 0001 BX 1.000
SPE2DP-26-T-3985
SECTION B
PR: 7015405663 PRLI: 0001 CONT’D
NSN/MATERIAL:6505017227590
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
N23197
USNS CARL BRASHEAR T-AKE 7
UNIT 100204 BOX 1
FPO AP 96661
US
SPE2DP-26-T-3985
SECTION B
PR: 7015405663 PRLI: 0001 CONT’D
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
N23197
USNS CARL BRASHEAR T-AKE 7
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N231976035S364
RDD: 777
PROJ: HJ5 TP 2
SUPP ADD: YMED S SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A41 DIST: 9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:02/09/2026
SPE2DP-26-T-3985 NSN/Part Number: 6505-01-722-7590 Quantity: 1 BX Purchase Request: 7015405663QTY: 1 Delivery: 20 days ADO

Similar Contracts

NAICS: 325411
New
DIBBS
KETOROLAC TROMETHAMINEKetorolac Tromethamine Injection, USP 15 mg per mL in prefilled syringes, 24’s per unit, is being procured under contract SPE2DP-26-T-4143 for delivery to Fort Bragg, North Carolina, with a required delivery date of July 13, 2026, and a five-day delivery window. The item is identified by NSN 6505-01-666-2156 and NDC 76045-0107-10, manufactured by FRESENIUS KABI, LLC, and must comply with DLA’s Master List of Technical and Quality Requirements, including Packaging Requirement RP001 and Shelf-life requirement RS016, which mandates a non-extendable 24-month shelf life. All packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and units must be sealed in commercial containers that ensure protection from damage during transit. The product must be shipped by the fastest traceable means, excluding parcel post, and labeled according to current Hazard Communication Standards (29 C.F.R. 1910.1200), including OSHA-compliant Safety Data Sheets and labels, as mandated post-June 2015. The quantity is one unit of issue (PG), with zero variance permitted, and inspection and acceptance occur at the destination. Packaging and palletization must follow DLA specifications, and government identification must not appear on non-accepted supplies. The contract requires full compliance with all applicable DLA technical and quality requirements, which take precedence over ASTM D3951 or other general commercial standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
ANALGESIC GEL, TOPICALThe contract specifies the procurement of an analgesic gel for topical use containing 5% menthol USP, supplied in 4 oz tubes with 144 tubes per case, classified as a flammable hazardous material requiring storage at 20–25°C (68–77°F) and protection from excessive heat or open flame. The item is identified by NSN 6505-01-658-7643 with a non-extendable shelf life of 24 months and must be packaged in commercial-grade containers that ensure protection from damage during transport, conforming to Medical Marking Standard No. 1 instead of MIL-STD-129. Shipment of the product must adhere to applicable hazard communication regulations, including the submission of Safety Data Sheets compliant with 29 C.F.R. 1910.1200 prior to award, and each shipment must include an accompanying SDS. Labels must meet OSHA’s revised Hazard Communication Standard aligned with the Globally Harmonized System, and supplier employees must be trained on these requirements. Packaging and transportation must comply with 49 CFR and ICAO regulations due to the flammable nature of the product, and all materials must be marked and documented in accordance with DLA’s hazardous material protocols, including electronic submission of SDS to DLA.MSDS@DLA.MIL. The contract is issued under solicitation SPE2DP-26-T-4115, requiring delivery within 20 days to Waterveciet, NY, and is managed by the Department of Defense’s Medical Supply Chain.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
BENZOCAINE AND MENTHOLBenzocaine and Menthol Lozenge, manufactured by RB Health US LLC and Reckitt Benckiser LLC, is a 15 mg benzocaine and 2.6 mg menthol oral pain reliever in honey lemon flavor, packaged in units of 16 lozenges, with a shelf life of 36 months that is non-extendable. The product must be stored at 20-25°C (68-77°F) and protected from humidity. All medical acquisitions require commercial packaging that ensures protection from damage or breakage, with each unit sealed in an appropriate container and shipped in exterior containers that guarantee safe, low-cost delivery to the destination. Material must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging must comply with DLA’s packaging requirements and palletization standards. The item is identified by NSN 6505017081449 and NDC 63824-0732-16, and is procured across five contract line items totaling 58 package units, each priced at $1.00 per unit, for total contract value of $58.00. Delivery is required within 20 days, FOB destination, with zero variance allowed in quantity, inspection and acceptance occurring at the delivery point. Shipments must be traceable, excluding parcel post, and sent to designated military logistics addresses at Fort Bragg, North Carolina, and Fort Stewart, Georgia. The solicitation, issued by the Department of Defense under contract SPE2DP-26-T-4113, has a response deadline of July 20, 2026, and requires compliance with all technical and quality requirements listed in the DLA Master List.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details